807618-13-9

Basic information

• Product Name: (1-(tert-butoxycarbonyl)piperidin-4-yl)zinc(II) iodide
• Synonyms: (1-(tert-butoxycarbonyl)piperidin-4-yl)zinc(II) iodide
• CAS NO: 807618-13-9
• Molecular Formula: C₁₀H₁₈INO₂Zn
• Molecular Weight: 376.54989
• Mol File: 807618-13-9.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1-(tert-butoxycarbonyl)piperidin-4-yl)zinc(II) iodide(CAS DataBase Reference)
• NIST Chemistry Reference: (1-(tert-butoxycarbonyl)piperidin-4-yl)zinc(II) iodide(807618-13-9)
• EPA Substance Registry System: (1-(tert-butoxycarbonyl)piperidin-4-yl)zinc(II) iodide(807618-13-9)

Safety Data

• Hazardous Substances Data: 807618-13-9(Hazardous Substances Data)

Upstream product

• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 301673-14-3 tert-butyl 4-iodopiperidine-1-carboxylate 
• 7440-66-6 zinc 

Downstream Products

• 1032900-25-6 5-chloro-N²-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N⁴-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine 
• 2361241-23-6 6-(1-{4-[4-(trifluoromethyl)phenoxy]benzoyl}piperidin-4-yl)pyridazin-3-amine 
• 1093217-87-8 5-(4-morpholin-4-ylphenyl)-1',2',3',4',5',6'-hexahydro-[2,4']bipyridinyl 
• 1093217-86-7 5-(4-morpholin-4-ylphenyl)-3',4',5',6'-tetrahydro-2'H-[2,4']bipyridinyl-1'-carboxylic acid tert-butyl ester 
• 1190399-91-7 5-chloro-N²-[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]-N⁴-[2-(isopropylsulfonyl)phenyl]pyrimidine-2,4-diamine dihydrochloride 
• 1032903-63-1 4-(4-amino-5-isopropoxy-2-methylphenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1227067-71-1 1-(4-(3-(4-(1H-benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)-2-fluoropropan-1-one 
• 1434271-69-8 tert-butyl 4-(4-(3-oxo-3-(pyridazin-4-yl)-1-o-tolylpropyl)phenyl)piperidine-1-carboxylate 
• 1093217-91-4 5-(4-ethanesulfonylphenyl)-1',2',3',4',5',6'-hexahydro-[2,4']bipyridinyl 
• 1093217-90-3 5-1,3-[benzodioxol-5-yl]-3',4',5',6'-tetrahydro-2'H-2,4'-bipyridinyl-1'-carboxylic acid tert-butyl ester dihydrochloride 

Relevant articles and documents

Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors

The leucine-rich repeat kinase 2 (LRRK2) protein has been genetically and functionally linked to Parkinson's disease (PD), a disabling and progressive neurodegenerative disorder whose current therapies are limited in scope and efficacy. In this report, we

HETEROCYCLIC GLP-1 AGONISTS

This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.

HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted benzothiazole compounds of Formula (I) or (II), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.